Integrated Biopharma Inc.

Packaged Foods • Consumer Defensive • Hillside, NJ, United States • INBP (OQX)

(888) 319-6962 Building 15, Hillside, NJ 07205, United States

Quarter: Q4 2025 Reported: December 1, 2025 Sentiment: Neutral

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Analysis Summary

The 2025 Annual Meeting of Stockholders for Integrated BioPharma, Inc. (INBP), held on December 1, 2025, concluded with the successful passage of all four proposals presented to shareholders. A quorum was established with 22,651,488 shares present, out of 31,059,610 eligible to vote.

**Detailed Voting Results:**
1. **Election of Class III Director:** Mr. Eric Friedman was elected to serve until the 2028 Annual Meeting, receiving 20,662,516 'For' votes, 183,398 'Withheld' votes, and 1,805,574 'Broker Non-Votes'. This ensures continuity and stability on the board.
2. **Non-binding, Advisory Vote on Frequency of Vote on Executive Compensation:** Shareholders overwhelmingly preferred a three-year frequency for future 'Say-on-Pay' votes, with 20,395,034 votes for '3 Years', compared to 445,580 for '1 Year' and 800 for '2 Years'. This indicates a desire for less frequent, but still regular, oversight on executive compensation.
3. **Non-binding Advisory Vote on Executive Compensation:** The executive compensation paid to Named Executive Officers was approved with substantial support, garnering 20,788,236 'For' votes against 56,978 'Against' votes and 700 'Abstain' votes. This reflects shareholder confidence in the current compensation structure.
4. **Ratification of Independent Auditors:** The appointment of CBIZ CPAs P.C. as the Company's independent auditors for the fiscal year ending June 30, 2026, was ratified with 22,536,930 'For' votes, 113,420 'Against' votes, and 1,138 'Abstain' votes, ensuring continued independent financial oversight.

**Management Commentary and Forward Guidance:** This 8-K filing is strictly a report on the outcomes of the Annual Meeting of Stockholders. It does not contain any management commentary on business performance, strategic initiatives, competitive positioning, market trends, forward guidance, or analyst Q&A highlights. Therefore, no financial performance breakdown or operational analysis can be derived from this document.

Key Highlights

• All four proposals at the 2025 Annual Meeting of Stockholders passed successfully.
• Mr. Eric Friedman was elected as a Class III director to serve until the 2028 Annual Meeting.
• Shareholders approved the executive compensation in a non-binding advisory vote with strong support.
• A three-year frequency for future advisory votes on executive compensation was preferred by shareholders.
• CBIZ CPAs P.C. was ratified as the independent auditors for the fiscal year ending June 30, 2026.
• A quorum of 22,651,488 shares was present, indicating strong shareholder participation.

Financial Metrics

eps

YoY: N/A - Not provided in this governance filing

revenue

N/A

YoY: N/A - Not provided in this governance filing

guidance

net income

N/A

YoY: N/A - Not provided in this governance filing

Stock Performance (90 Days)

Data through Dec 26, 2025

Layoff Events

Earnings Calls

Positive Signals

• Strong shareholder support for all board-recommended proposals.
• Successful election of director ensures board continuity and stability.
• Clear shareholder preference for a three-year 'Say-on-Pay' frequency provides clarity for future governance.
• Ratification of independent auditors indicates stable and consistent financial oversight.
• High quorum achieved demonstrates active shareholder engagement and participation.

Risks & Concerns

— No specific business or financial risk factors were discussed or raised in this governance-focused 8-K filing.
— The document does not provide insight into operational challenges, market competition, or future financial outlook.
— Reliance on this filing alone would not provide a complete picture of the company's financial health or strategic risks.